Status:
WITHDRAWN
Interleukin-4 (IL-4) as a Marker of Atherosclerosis
Lead Sponsor:
Melbourne Health
Collaborating Sponsors:
The Intensive Care Unit Departmental Funding
Conditions:
Atherosclerosis
Ischemic Heart Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
In recent years, medical research into the cause and progression of heart disease due to narrowing and blockage of blood vessels to the heart muscle has improved the understanding of ischemic heart di...
Detailed Description
This is a single centre, prospective, non randomised, non controlled, pilot study of the potential abnormality of a new test group of patients in whom the results are postulated to be abnormal. The s...
Eligibility Criteria
Inclusion
- All patients (either sex and any age) presenting in the settings described will be eligible to participate.
Exclusion
- An unwillingness to participate.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00256035
Last Update
April 27 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.